A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating ...

A study from the University of Birmingham has indicated that digoxin could be used to treat senior individuals with heart ...

The dose of the first- or second-generation β blocker that the patient is receiving is an important consideration for the switching regimen chosen. The major factors to be kept in mind when ...

Beta blockers have been shown to prolong survival in chronic heart failure. It is currently a matter of debate whether any β blocker is superior to the other in terms of improving symptoms ...

Using a most cost-effective drug to treat some of the most common and dangerous heart conditions could save the NHS a ...

The following is a summary of “Cost-effectiveness of digoxin versus beta blockers in permanent atrial fibrillation: the Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF) ...

First used in 1785, this century-old medication is now emerging as a modern solution with significant healthcare benefits ...

A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating older patients with atrial fibrillation and heart failure.

Background Early heart failure (HF) diagnosis is crucial to ensure that optimal guideline-directed medical therapy (GDMT) is ...